NetMHCpan 4.0: Improved peptide-MHC class I interaction predictions integrating eluted ligand and peptide binding affinity data
2017
529 citations recorded by the source corpus.
Cytotoxic T cells are of central importance in the immune system’s response to disease. They recognize defective cells by binding to peptides presented on the cell surface by MHC (major histocompatibility complex) class I molecules. Peptide binding to MHC molecules is the single most selective step in the antigen presentation pathway. On the quest for T cell epitopes, the prediction of peptide binding to MHC molecules has therefore attracted large attention. In the past, predictors of peptide-MHC interaction have in most cases been trained on binding affinity data. Recently an increasing amount of MHC presented peptides identified by mass spectrometry has been published containing information about peptide processing steps in the presentation pathway and the length distribution of naturally presented peptides. Here, we present NetMHCpan-4.0, a method trained on both binding affinity and eluted ligand data leveraging the information from both data types. Large-scale benchmarking of the method demonstrates an increased predictive performance compared to state-of-the-art when it comes to identification of naturally processed ligands, cancer neoantigens, and T cell epitopes.
Subfields: Immunology, Molecular Biology, Radiology, Nuclear Medicine and Imaging
Citations in the corpus
- Mapping the Landscape of Artificial Intelligence Applications against COVID-19 (2020, unknown): “The search for the T-cell epitopes relies on two previously-developed neural networks to predict MHC presentation, NetMHCPan4 (Ju-rtz et al., 2017) and MARIA (Chen et al., 2019).”
- Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals (2020, unknown): “…overlap between different HLA class I allelic variants and loci is more limited to specific groups of alleles, or supertypes (Sidney et al., 2008 (Jurtz et al., 2017) for the top 12 more frequent HLA alleles and selecting the top 1 percentile predicted epitope per HLA allele clustered with…”